i've constantly read your posts and apprciate your knowledge and insight about celgene. You mentioned in your most previous message that celgene is close to an imid and ritalin deal. what i'd also like to ask you is, when do you expect doctors to come out with other peer reviews on other indications for thalidomide( perhaps doctor Gruber at NYU or brain cancer, chrons disease). Also, what is your feeling on the december sales regarding thalidomide? even if the quarter sales are not spectacular, as long as december is good (1 1/2 million) i belive that the stock price will be given a strong boost.Lastly, what is your opnion of the activity at the end of trading on friday, with the 100,000 blocks. do you belive that this was institutions or shorts buying back. thanks again for your intelligent insight. good luck to all celgene shareholders.